Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2499432rdf:typepubmed:Citationlld:pubmed
pubmed-article:2499432lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:2499432lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:2499432lifeskim:mentionsumls-concept:C0022661lld:lifeskim
pubmed-article:2499432lifeskim:mentionsumls-concept:C0085201lld:lifeskim
pubmed-article:2499432lifeskim:mentionsumls-concept:C1996904lld:lifeskim
pubmed-article:2499432lifeskim:mentionsumls-concept:C1880497lld:lifeskim
pubmed-article:2499432pubmed:issue6lld:pubmed
pubmed-article:2499432pubmed:dateCreated1989-7-21lld:pubmed
pubmed-article:2499432pubmed:abstractTextWe determined, immunoturbidimetrically, the concentrations of apolipoprotein A-I (apo A-I) (a) in total serum, (b) in total lipoproteins, and (c) in the fraction of d greater than 1.21 kg/L (free apo A-I) in 31 uremic patients (16 on hemodialysis, HD, and 15 with end-stage renal failure, ESRF) and 14 control subjects. The concentration of free apo A-I in serum was significantly increased in both groups of uremic patients (0.27 +/- 0.07 g/L for HD and 0.22 +/- 0.08 g/L for ESRF, mean +/- SD), in comparison with the control group (0.14 +/- 0.04 g/L). The ratio of total apo A-I to high-density-lipoprotein cholesterol was significantly increased in sera from both uremic groups, whereas the apo A-I/HDL-chol ratio of total lipoproteins was similar in all three groups. No apo A-I could be detected in five ultrafiltrates of plasma, even after 100-fold concentration. Analysis of apo A-I isoforms by isoelectrofocusing revealed a significant relative increase in apo A-I3 and a decrease in apo A-I5 isoform in ESRF patients, but not in HD patients. Finally, we found no relationship between serum TG and free apo A-I concentration.lld:pubmed
pubmed-article:2499432pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:languageenglld:pubmed
pubmed-article:2499432pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:citationSubsetIMlld:pubmed
pubmed-article:2499432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2499432pubmed:statusMEDLINElld:pubmed
pubmed-article:2499432pubmed:monthJunlld:pubmed
pubmed-article:2499432pubmed:issn0009-9147lld:pubmed
pubmed-article:2499432pubmed:authorpubmed-author:DrüekeTTlld:pubmed
pubmed-article:2499432pubmed:authorpubmed-author:DuvalFFlld:pubmed
pubmed-article:2499432pubmed:authorpubmed-author:LacourBBlld:pubmed
pubmed-article:2499432pubmed:authorpubmed-author:AtgerVVlld:pubmed
pubmed-article:2499432pubmed:authorpubmed-author:FrommherzKKlld:pubmed
pubmed-article:2499432pubmed:issnTypePrintlld:pubmed
pubmed-article:2499432pubmed:volume35lld:pubmed
pubmed-article:2499432pubmed:ownerNLMlld:pubmed
pubmed-article:2499432pubmed:authorsCompleteYlld:pubmed
pubmed-article:2499432pubmed:pagination963-6lld:pubmed
pubmed-article:2499432pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:meshHeadingpubmed-meshheading:2499432-...lld:pubmed
pubmed-article:2499432pubmed:year1989lld:pubmed
pubmed-article:2499432pubmed:articleTitleInfluence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum.lld:pubmed
pubmed-article:2499432pubmed:affiliationINSERM U 90, Hôpital, Necker, Paris, France.lld:pubmed
pubmed-article:2499432pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2499432lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2499432lld:pubmed